De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Kyongbo Pharmaceutical Beheer
Beheer criteriumcontroles 0/4
Momenteel beschikken wij niet over voldoende informatie over de CEO.
Belangrijke informatie
Tae-Young Kim
Algemeen directeur
n/a
Totale compensatie
Percentage CEO-salaris | n/a |
Dienstverband CEO | no data |
Eigendom CEO | n/a |
Management gemiddelde ambtstermijn | geen gegevens |
Gemiddelde ambtstermijn bestuur | geen gegevens |
Recente managementupdates
Recent updates
Kyongbo Pharmaceutical (KRX:214390) Has A Somewhat Strained Balance Sheet
Mar 09What Type Of Shareholders Own The Most Number of Kyongbo Pharmaceutical Co., Ltd (KRX:214390) Shares?
Feb 02Kyongbo Pharmaceutical Co., Ltd's (KRX:214390) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?
Jan 12Did You Miss Kyongbo Pharmaceutical's (KRX:214390) Impressive 107% Share Price Gain?
Dec 25Is Kyongbo Pharmaceutical (KRX:214390) A Risky Investment?
Dec 08Does Kyongbo Pharmaceutical's (KRX:214390) Statutory Profit Adequately Reflect Its Underlying Profit?
Nov 18CEO
Tae-Young Kim
no data
Tenure
Tae-Young Kim is Chief Executive Officer of Kyongbo Pharmaceutical Co., Ltd.